Manage lung cancer as an end-to-end access and reliability challenge
World Lung Cancer Day is observed annually on August 1 to elevate prevention, early detection, treatment, and support. The executive opportunity is not another ribbon campaign. It is a disciplined review of whether the health system can identify people who may benefit from screening, support informed decisions, complete appropriate low-dose CT, close abnormal-result loops, reach diagnosis without avoidable delay, and connect every patient to coordinated treatment and support.
CDC’s current public guidance reports that only about 18% of U.S. adults for whom lung cancer screening is recommended have been screened. Screening is not appropriate for everyone, and eligibility depends on current clinical guidance and individual risk. The operational gap is therefore two-sided: leaders must reduce underuse among eligible patients while preventing indiscriminate testing outside evidence-based pathways. Review current CDC lung cancer screening guidance.
Executive interpretation: The rate is a national estimate, not a local target. It should prompt a denominator audit, capacity review, and stratified access analysis. A high order count is not success if patients never complete imaging or abnormal findings remain unresolved.
Six stages that must function as one service
Most organizations own the individual departments needed for lung cancer screening and care. Fewer manage the handoffs as one accountable pathway. Use World Lung Cancer Day to identify the executive owner, operational owner, clinical governance lead, and data steward for each stage.
Identify
Reliable age, smoking-history, risk, and contact dataDecide
Informed, documented shared decision makingComplete
Accessible, high-quality low-dose CT capacityTrack
Closed-loop results and nodule surveillanceResolve
Timely diagnostic evaluation and tissue diagnosisTreat
Navigation, multidisciplinary care, and supportRemove failure points before adding campaign volume
Screening programs cannot manage what the EHR cannot identify. Standardize the capture of smoking history, pack-year information, quit timing, prior screening, symptoms, and exclusions in structured fields, while recognizing that clinical decisions require current guidance and individual assessment. Audit missingness by clinic, payer, language, race and ethnicity, and geography. Apply the data-governance discipline described in leveraging data analytics for improved patient outcomes.
- Assign ownership for structured history completeness and correction.
- Validate registry logic against chart review before launching outreach.
- Separate eligible, potentially eligible, previously screened, declined, deferred, and diagnostic populations.
Map demand against imaging hours, geographic reach, payer requirements, transportation, language access, and shared-decision capacity. Patient reminders and clinician prompts can help, but they should connect to appointments that are actually available. AHRQ-supported work on EHR-integrated decision support shows how workflow design can improve appropriate screening activity without relying on memory alone. Explore the AHRQ Decision Precision+ implementation story.
- Measure days from identification to decision visit and from order to completed scan.
- Offer navigation before the patient encounters an authorization or transportation barrier.
- Pair screening access with evidence-based tobacco-treatment referral where appropriate.
An abnormal scan is not an outcome. It is the beginning of a time-sensitive coordination process that may include comparison imaging, surveillance, specialty evaluation, diagnostic testing, and multidisciplinary review. Build one work queue with named ownership, escalation rules, and backup coverage. Track open findings by acuity and elapsed time, not only by department. This same enterprise discipline should extend the organization’s broader cancer control strategy.
- Define which team owns each result from release through documented resolution.
- Escalate unreachable patients and care transitions through a standard pathway.
- Audit incidental pulmonary nodules discovered outside the screening program.
Screening and diagnostic averages can conceal meaningful gaps. Stratify the pathway by site, rurality, payer, race and ethnicity, language, disability, and other locally relevant dimensions. Combine quantitative results with patient and community feedback about stigma, fear, transportation, trust, and cost uncertainty. The goal is not a separate equity campaign. It is the operational practice described in our brief on operationalizing health equity.
- Compare outreach, completion, follow-up, and resolution rates across groups.
- Fund community health workers and navigators where barriers concentrate.
- Use plain-language materials that distinguish screening from diagnostic evaluation.
Cigarette smoking remains the leading risk factor, but lung cancer also occurs among people who never smoked. CDC estimates that 10% to 20% of U.S. lung cancers occur in people who never smoked or smoked fewer than 100 cigarettes in their lifetime. Radon, secondhand smoke, and occupational exposures also matter. Leaders should align tobacco treatment, environmental health, primary care, oncology, palliative care, and survivorship without stigmatizing patients. Our Radon Awareness Month leadership brief offers a complementary environmental-health lens.
- Train staff to use nonjudgmental language across the pathway.
- Integrate symptom escalation and diagnostic routes outside screening eligibility.
- Coordinate survivorship, behavioral health, financial navigation, and serious-illness support.
Track conversion, time, reliability, and equity
| Stage | Core measure | Leading signal | Primary owner |
|---|---|---|---|
| Identification | Potentially eligible population with complete risk data | Missing structured smoking history | Primary care, CMIO, data governance |
| Decision | Appropriate shared-decision completion | Referral and scheduling abandonment | Population health and ambulatory operations |
| Imaging | Order-to-completion time and completion rate | Capacity by site, day, and access channel | Radiology executive |
| Follow-up | Findings resolved within the clinically directed interval | Open or aging result work queues | Quality leader and program medical director |
| Diagnosis | Time from suspicious finding to diagnostic resolution | Handoff delay across specialties | Oncology and service-line operations |
| Equity | Gap in completion and resolution across local groups | Outreach-to-appointment conversion | Population health and community partnerships |
Set targets through clinical governance and current federal, payer, professional, and jurisdictional guidance. National percentages should inform inquiry, not become automatic local quotas.
Move from awareness to pathway control
Name owners and expose the gaps
- Confirm current clinical and coverage requirements.
- Validate the denominator and map every handoff.
- Baseline access, completion, follow-up, resolution, and equity.
- Identify the highest-risk backlog or work-queue failure.
Remove priority friction
- Repair risk-data capture and referral workflows.
- Open targeted capacity where demand is constrained.
- Standardize result ownership and escalation.
- Launch navigation for the highest-barrier populations.
Hardwire accountability
- Review the pathway dashboard with the executive team.
- Audit a sample from identification through resolution.
- Publish corrective actions and accountable due dates.
- Carry unresolved capital and workforce needs into planning.
A scan is only valuable when the pathway delivers the next right action
World Lung Cancer Day gives executive teams a defined moment to inspect a service that crosses primary care, radiology, pulmonology, surgery, oncology, pathology, navigation, community health, information technology, and revenue cycle. Fragmented ownership is therefore a predictable risk, not a surprise.
The strongest leadership response is a single operating pathway with reliable eligibility data, appropriate access, closed-loop findings, timely diagnostic resolution, stratified performance, and transparent accountability. This approach complements the equity commitments in our World Cancer Day executive brief and turns awareness into durable system performance.
Do not measure success by the number of scans ordered. Measure whether the right people complete appropriate screening and whether every finding reaches a documented resolution.